ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-Gly-Ser(Psi(Me,Me)Pro)-OH
C23H24N2O6
424.4 g/mol
Research Reagent

Fmoc-Gly-Ser(Psi(Me,Me)Pro)-OH

CAS1095952-22-9
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a research reagent used as a building block in peptide synthesis.

Peptide synthesis building blockLaboratory research reagent

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Gly-Ser(Psi(Me,Me)Pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

Fmoc-Ala-Gly-OH

CAS116747-54-7

research compound

ApplicationSame Use

Allyl (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-aminobutanoate

CAS688316-86-1

research compound

ApplicationSame Use

L-Valinamide hydrochloride

CAS3014-80-0

research compound

ApplicationSame Use

N-Formylglycine ethyl ester

CAS3154-51-6

research compound

ReferenceSame Category

2-Chloro-3-fluoro-4-nitropyridine

CAS109613-90-3

research compound

ReferenceSame Category

6-Methyl-2-phenyl-1,3,6,2-dioxazaborocane-4,8-dione

CAS109737-57-7

research compound

ReferenceSame Category

N-(3-Methoxybenzyl)-2,4-dimethylbenzamide

CAS1097449-03-0

research compound

ReferenceSame Category

N-(9-Fluorenylmethyloxycarbonyl)-D-glutamic acid 1-tert-butyl ester

CAS109745-15-5

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4S)-3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid

InChIKey

XUBXHZJERGBCEL-IBGZPJMESA-N

SMILES

CC1(N([C@@H](CO1)C(=O)O)C(=O)CNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C

Synonyms (11)
  • Fmoc-Gly-Ser(|xMe, Mepro)-OH

Sourcing Fmoc-Gly-Ser(Psi(Me,Me)Pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→